Acorda CEO Cohen on U.S. Budget Cuts, Research

March 22 (Bloomberg) -- Ron Cohen, chief executive officer of Acorda Therapeutics Inc., talks about the impact of U.S. budget cuts on medical research and drug development. Cohen, speaking with Sara Eisen and Tom Keene on Bloomberg Television's "Surveillance," also discusses China's investment in medical care and science. (Source: Bloomberg)
Six Years of Record Low Rates in the U.K.
39:29 - March 5 -- Bank of England Founding Member of the MPC Deanne Julius discusses monetary policy and inflation on “The Pulse.”
  • AbbVie Buys Pharmacyclics in $21B Deal
  • Standard Bank Gains Most in 6 Years on Africa Business
  • Serious Fraud Office Investigating BOE Liquidity Auctions